approval · primary record
INSULIN ASPART-FSAN
FDA · BLA · 2026-09-15
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-09-15 |
| Brand | GARZULYS |
| Sponsor | EMERGE BIOSCIENCE PTE. LTD. |
| Route | MULTIDOSE |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:40:43.049Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:INSULIN ASPART-FSAN:2026-09-15
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Insulin Aspart-Fsan · compound